Mineralys Therapeutics, Inc. - Common Stock (MLYS) — AI analysis & news
Mineralys Therapeutics, Inc. - Common Stock (MLYS) stock: 7 recent news items, negative aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 7 indexed MLYS stories, aggregate finance-aware sentiment is negative (-0.36 on a -1 to +1 scale).
Latest MLYS news
- Mineralys Therapeutics stock hits 52-week low at 20.4 USD By Investing.com - Investing.com UK · Investing.com UK
- Mineralys Therapeutics stock hits 52-week low at 22.23 USD By Investing.com - Investing.com India · Investing.com India
- Mineralys Therapeutics stock hits 52-week low at 22.23 USD By Investing.com - Investing.com UK · Investing.com UK
- Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com Nigeria · Investing.com Nigeria
- Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com UK · Investing.com UK
- Mineralys Therapeutics CCO Eric Warren sells $209k in stock By Investing.com - Investing.com India · Investing.com India
- Mineralys Therapeutics director Karydas sells $85,740 in stock - Investing.com India · Investing.com India
FAQ
What is the current sentiment for MLYS stock?
Aggregate finance-aware sentiment across the last 7 indexed MLYS news stories is negative (-0.36 on a -1 to +1 scale).